Tubulis Gmbh
Clinical trials sponsored by Tubulis Gmbh, explained in plain language.
-
Can a targeted drug delivery system shrink lung tumors?
Disease control Not yet recruitingThis trial tests an experimental drug called TUB-040 in adults with advanced non-small cell lung cancer that cannot be removed with surgery or has spread. TUB-040 is designed to attach to a protein on cancer cells and deliver a toxic payload directly to the tumor, potentially kil…
Phase 2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a smart drug deliver a lethal payload to endometrial cancer?
Disease control Not yet recruitingThis study tests an experimental drug called TUB-040 in people with recurrent or progressive endometrial cancer that has not responded to platinum-based chemotherapy and immunotherapy. TUB-040 is an antibody-drug conjugate designed to bind to a protein called NaPi2B on cancer cel…
Phase 1/2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC